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Abstract
RNA-mediated gene silencing, in the form of RNA interference (RNAi) or microRNAs (miRNAs) has provided novel tools for
gene discovery and validation in mammalian cells. Here, we report on the construction and application of a random small
RNA expression library for use in identifying small interfering RNA (siRNA) effectors that can modify complex cellular
phenotypes in mammalian cells. The library is based in a retroviral vector and uses convergent promoters to produce
unique small complementary RNAs. Using this library, we identify a range of small RNA-encoding gene inserts that
overcome resistance to 5-fluorouracil (5-FU)- or tumour necrosis factor alpha (TNF-a)- induced cell death in colorectal cancer
cells. We demonstrate the utility of this technology platform by identifying a key RNA effector, in the form of a siRNA, which
overcomes cell death induced by the chemotherapeutic 5-FU. The technology described has the potential to identify both
functional RNA modulators capable of altering physiological systems and the cellular target genes altered by these
modulators.
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Introduction
The introduction of double-stranded RNA (dsRNA) into a
range of organisms induces both a potent and specific gene
silencing effect termed RNA interference (RNAi) [1]. These
dsRNAs are processed by Dicer to produce 21–23 nucleotide
duplex small interfering RNAs (siRNA) with 2 nucleotide 39 OH
overhangs that act as the effectors of gene silencing [2].
Furthermore, it has been demonstrated that chemically synthe-
sised 21 bp siRNAs can be used to induce gene silencing in
mammalian cells [3,4]. The transient nature of the gene silencing
effect invoked by siRNAs, and the prohibitively high costs of
chemical synthesis, has led to the development of DNA vectors
capable of expressing siRNAs intracellularly. Expression cassettes
have been developed using the endogenous U6 small nuclear RNA
(snRNA) or H1 RNA polymerase III promoters to drive
expression of sequence-specific small hairpin RNAs (shRNAs)
that stably regulate gene expression in mammalian cells via RNAi
[5,6]. As an alternative approach, some groups have used the co-
expression of sense and antisense RNA strands from independent
expression cassettes or a divergent promoter [7]. The use of
convergent transcription from opposing promoters to induce
RNAi-mediated gene inhibition has been reported in trypano-
somes and Drosophila [8,9]. More recently, convergent transcrip-
tion-induced RNAi has been demonstrated to be an effective way
of controlling specific gene expression in mammalian cells [10,11].
RNAi is also a powerful genetic tool for loss-of-function studies.
Large-scale RNAi libraries have been generated for use in forward
genetics screens with the aim of linking genes with specific cellular
phenotypes [12,13]. Genome-wide RNAi-based genetic screens were
first demonstrated in C.elegans and Drosophila cells [14,15]. More
recently, this genetic screening approach has been applied to
mammalian cell systems using different forms of RNAi libraries.
Initially, large-scale shRNA expression libraries were constructed
using computational algorithms and ‘‘bar-coded’’ oligonucleotides
[16,17]. With a better understanding of the characteristics associated
with natural miRNA processing and to improve the efficiency of
shRNA activity, second generation genome-wide shRNA libraries
were produced using pre-miRNA flanking sequences [18]. The above
librarieshavebeenusedforloss-of-functionstudiesinmammaliancell
culture and to identify pre-selected genes contributing to complex
cellular phenotypes. In an alternative strategy for producing targeted
shRNA libraries, several groups have developed enzymatic methods
for converting cDNAs into shRNAs for use in genetic screening [19–
21]. All of the aforementioned libraries target specific protein coding
genes or restricted cDNA sub-populations and are particularly useful
for identifying single gene targets involved in a biological or disease
process. These libraries do not necessarily permit the identification of
completely novel small RNAs or targets involved in complex cellular
physiology.
In addition to the use of shRNAs several groups have reported on
the use of convergent transcription to direct RNAi-mediated
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RNA polymerase II or III promoters are used to drive transcription
of sense and antisense RNAs from a single DNA insert. The
complementary RNAs then form a duplex RNA which is processed
by Dicer and loaded into the RNA induced silencing complex
(RISC). Different forms of convergent RNAi libraries have been
produced and used in genetic selections [22–24]. However, as with
the majority of genome-wide shRNA libraries, these libraries are
restricted to surveying previously reported target genes.
One alternative to the production of RNAi expression libraries
using known genes involves the generation of random libraries
capable of expressing a universal set of shRNAs or siRNAs.
Several enzymatic methods have been described for the produc-
tion of shRNA expression libraries using degenerate oligonucle-
otides [25–27]. Most recently, a random shRNA-encoding
retroviral library was used to identify shRNA sequences that
double the survival of mouse pro-B cells following IL-3 withdrawal
[28]. Random mutagenesis and re-screening were then used to
further optimize the shRNA hits toward the development of novel
therapeutics. Convergent promoter-based random siRNA expres-
sion libraries have been produced by cloning random 19-mer
DNA sequences between two opposing RNA polymerase III
promoters in plasmid vectors [29]. This library was used for
phenotype-driven screening to identify siRNAs inducing cell
growth. The advantages associated with using a convergent
promoter format for producing random RNAi libraries are the
potential for producing small RNAs that operate by canonical and
non-conventional mechanisms to control single or multiple target
genes and the possibility of discovering novel, multifunctional
small RNAs capable of modifying complex cellular phenotypes.
These small RNAs have the potential to be novel therapeutics or
biological tools. Unfortunately, there have been few reports of the
use convergent random RNAi libraries for genetic screening in
mammalian cells and these have been restricted to the use of
plasmid-based libraries.
Here, we report on the development and application of a
convergent random small RNA expression library for use in
mammalian cell types to isolate novel RNAs capable of modifying
complex cellular phenotypes. This retrovirally-based expression
library was used in two independent unbiased genetic selection
assays aimed at overcoming cell death induced by the chemo-
therapeutic 5-FU or the cytokine TNF-a. Using this approach,
novel small RNA effectors were identified that alter these
phenotypes. Further analysis demonstrated that one of these
effectors operated through the canonical RNAi pathway. We
discuss the utility of this technology for finding new gene functions
through phenotypic selection and discovering novel small RNAs
that can be used to manipulate complex cellular phenotypes
associated with human disease states.
Results
Production of retroviral vector with convergent
promoters
In a previous study we reported on the use of convergent
transcription from two U6 RNA polymerase III promoters in a
plasmid-based system to induce RNAi-mediated gene silencing in
mammalian cells [10]. The suppression of target gene expression
was dependent on Dicer and the convergent promoter cassette
operated in both transiently and stably transfected cell popula-
tions. To develop a random small RNA expression library suitable
for large-scale genetic selections, we constructed a modified
pLXSN retroviral vector containing the human U6 and H1
RNA polymerase III promoters in opposite orientation to each
other (designated pHybrid). Retroviral vectors have been success-
fully used for both biased and unbiased genetic screens in
mammalian cells and provide an optimal vehicle for delivery of
highly complex genetic libraries [12].
To determine whether the convergent U6/H1 expression
cassette could produce functional siRNA that mediated effective
gene suppression, an insert encoding a p53-specific siRNA [6] was
enzymatically-generated (as described in materials and methods)
and cloned into pHybrid (Figure 1A). The pHybrid-p53 retroviral
vector was transduced into HCT116 cells and Western analysis
performed on both pooled populations and single clone isolates to
determine the effect of siRNA expression on p53 protein levels. As
shown in figure 1B, convergent transcription of the p53-specific
insert resulted in a 50% reduction in p53 protein levels within both
the pooled population (Figure 1B, lane 2), and two clonal lines
(Figure 1B, lanes 3 and 5), when compared to vector controls
(Figure 1B, lanes 1 and 4, respectively). We also examined the
responsiveness of these clones to 5-FU treatment and showed that
cells containing the pHybrid-p53 construct displayed an increased
proliferative potential and reduced apoptosis (data not shown), a
phenotypic profile consistent with resistance to 5-FU treatment.
Given the use of a convergent promoter cassette, and the
expression of two complementary RNAs with the potential to form
dsRNA, there were several possible ways by which the RNA
effector encoded in pHybrid-p53 could direct suppression of p53
gene expression. To examine the mechanism of p53 suppression,
we attenuated the levels of Dicer, a key enzyme involved in the
processing of dsRNA to produce effective siRNA, by using a
synthetic siRNA targeted against Dicer mRNA [30]. Delivery of
Dicer-specific siRNA to cells stably containing pHybrid-p53
restored p53 protein levels to basal levels in a dose-dependent
manner (Figure 1C, lanes 5–7). In contrast, the same cells
transfected with a negative control siRNA, having no known target
within mammalian cells, displayed the same 50% reduction in p53
protein (Figure 1C, lane 8). Furthermore, there was no modulation
of p53 protein in vector control cells transfected with the same
dose of siRNA specific for Dicer (Figure 1C, lanes 2–4). These
results indicate that the convergent transcription of the p53-
specific insert in pHybrid-p53 produced siRNA that was effective
at reducing p53 protein levels and this suppression was Dicer-
dependent.
Generation of a randomized small RNA retroviral
expression library
Following the confirmation of the activity of the U6 and H1
promoters within the context of the retroviral vector backbone, we
constructed and characterised an expression library in pHybrid
containing random insert sequences. The starting synthetic
oligonucleotide was composed of 19 nucleotides of randomised
sequence flanked on the 59 end with a primer-binding site, an
XhoI site and five adenosines. On the 39 side of the randomised
nucleotides was a string of five thymidines followed by an XbaI site
and a second primer-binding site. Using the enzymatic method
described in Figure 2, a pool of randomised double-stranded DNA
inserts was produced and cloned into pHybrid. To reduce the
presence of concatemers, and increase the proportion of library
members with single inserts, we used sequential end ligation [31].
In this process, the dsDNA oligonucleotides were ligated in excess
to a de-phosphorylated plasmid using one compatible overhang,
resulting in a pool of linear plasmids containing insert(s) in either
orientation. Further enzymatic digestion to generate the second
compatible overhang allows intramolecular ligation and plasmid
circularisation. Using this method, we produced a random small
RNA expression library composed of approximately half a million
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were unique and aligned to different regions of the human
genome. Although the complexity of the library was rather low,
the use of convergent promoters provided the potential to encode
small antisense RNAs, sense RNAs, dsRNAs or microRNA-like
RNAs from a single library plasmid member.
RNA effector identification using the small RNA
expression library
The random small RNA library was used in two independent
functional screens to identify RNA effectors conferring resistance
to 5-FU- or TNF-a-induced apoptosis. This library was delivered
to HCT116 cells and a pooled population generated following
eight days of selection in the presence of G418. These cells were
subjected to either 400 uM 5-FU treatment for 18 h or 25 ng/ml
TNF-a and 50 ug/ml cycloheximide co-treatment for 72 h,
conditions that were previously determined to induce cellular
apoptosis in HCT116 cells (data not shown). The surviving
resistant clones were isolated, genomic DNA extracted, library
inserts recovered by PCR and insert sequences identified by
sequence analyses (Figure 3A). A total of 430 and 500 resistant
clones were recovered with 5-FU treatment and TNF-a plus
cycloheximide co-treatment, respectively. The number of back-
ground colonies identified using the same conditions on vector
alone cells was only 20–25% of the number obtained with the
library-containing cells (Figure 3B). This suggested that library
constituents existed that potentially overcame 5-FU or TNF-a-
induced cell death.
From the 5-FU and TNF-a genetic selections, the library insert
sequences from a total of 163 and 73 independently-derived
HCT116 resistant clones were determined, respectively. Of
particular interest was the enrichment of a single insert sequence
in 55 independent 5-FU resistant clones of the 163 clones
analysed. This insert sequence (designated 5FU55) was not
represented in the any of 384 sequences of the library prior to
selection or in any of the sequences identified among the clones
resistant to TNF-a-induced cell death. To validate this insert
sequence as conferring resistance to 5-FU, the 5FU55 DNA was
recovered by PCR from a 5-FU resistant clone in the original
screen, re-cloned into pHybrid to produce pHybrid-5FU55 and
re-delivered into HCT116 cells via retroviral transduction. Single
clones containing either the vector alone or pHybrid-5FU55 were
obtained following selection and characterised for resistance to 5-
Figure 1. RNAi-mediated suppression of p53 using convergent transcription within the retroviral vector pHybrid-p53. (A) Schematic
of the core pHybrid-p53 vector including the p53-specific insert sequence encoding sense and antisense RNAs. The core pHybrid vector contains the
human U6 and H1 promoters in opposing orientation. (B) Suppression of p53 protein levels in HCT116 pooled populations and clones stably
transduced with pHybrid-p53. HCT116 cells transduced with pHybrid-p53 were selected in G418 for eight days to produce stable pools. These pooled
populations were serially diluted to isolate stable clones (indicated by V7 for pHybrid alone and C1 and C8 for pHybrid-p53). Total protein lysates
were assessed for levels of p53 and b-actin, the latter as the loading control. (C) Dicer-dependent control of convergent transcription-induced
suppression of p53. HCT116 stable clones containing pHybrid (V7) or pHybrid-p53 (C8) were transiently transfected with different concentrations of
the Dicer-specific siRNA (Dicer) or a single concentration of the negative control siRNA (Neg). Levels of p53 and b-actin were determined from
isolated protein lysates.
doi:10.1371/journal.pone.0004758.g001
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formed colonies following exposure to 5-FU, with cellular
resistance ranging from intermediate to robust (compare clones
8 and 6, respectively, in figure 4A). In contrast, HCT116 cells
transduced with the vector alone displayed only background
colony formation (Figure 4A). All clones receiving either pHybrid
or pHybrid-5FU55 showed similar growth profiles in the absence
of 5-FU treatment, suggesting that the small RNA effector
expressed from the 5FU55 DNA did not alter general cell
physiology.
Synthetic 5FU55 siRNA
To further define the RNA effector encoded by the 5FU55
insert, and determine whether small RNAs identified using the
random small RNA library could be converted to synthetic RNA
effectors, we designed and tested a synthetic siRNA corresponding
to the unique sequence contained in the 5FU55 insert. HCT116
cells were transiently transfected with the 5FU55-siRNA and cells
exposed to 400 uM 5-FU and examined for clone formation using
a clonogenic assay. In comparison to HCT116 cells transfected
with the negative control siRNA, cells receiving the 5FU55 siRNA
displayed a dose-dependent increase in colony formation following
exposure to 5-FU (Figure 4B). This suggests that the insert
contained within the original random library insert encoded for a
siRNA capable of modifying the chemosensitivity phenotype of
HCT116 cells. Interestingly, simple sequence alignment analysis
using the passenger or guide RNA strands of 5FU55 and the
publicly available human RefSeq database did not identify a single
target transcript with complete complementarity to these small
RNA sequences. Instead, using the criteria of at least 14 bases of
contiguous complementarity with the 59 end of the guide strand,
we identified 14 different target mRNAs with the potential to form
a partial duplex. The targets identified included the homeodo-
main-interacting protein kinase-2 (HIPK2), tektin 1, a lipid raft
Figure 2. Enzymatic synthesis of inserts for construction of the random small RNA expression library. A 63 base oligonucleotide,
composed of 19 random nucleotides (N) flanked by five adenosines and five thymidines, XhoI and XbaI restriction sites and primer binding sites, was
extended to produce a second strand using the indicated primer (A). This dsDNA template was amplified with PCR primers (B) and subject to XhoI
digestion (C). Following ligation to the SalI-digested pHybrid (D) and isolation of ligated products, the mix was digested with XbaI (E) and subjected
to intramolecular ligation to produce the final random siRNA library (F).
doi:10.1371/journal.pone.0004758.g002
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family (keratin 73). These results suggest that the 5FU55 siRNA
conferred resistance to 5FU by directly or indirectly modulating
the expression levels of more than one target gene product.
Discussion
In this paper we describe the construction and characterisation
of a random small RNA expression library and demonstrate the
utility of this library for identifying small RNA effectors that alter
complex cellular phenotypes. Using two different genetic selection
assays, we identified constituents within the library that encode
small RNAs capable of overcoming both 5-FU and TNF-a-
induced apoptosis. Following one round of genetic selection for
resistance to 5-FU, a single insert was enriched and contained
within 30% of the 5-FU-resistant clones. The link between this
library insert and the 5-FU resistant phenotype was confirmed by
re-delivering the specific vector containing this insert. Moreover,
the novel sequence contained within the insert was used to both
identify potential target proteins directly or indirectly suppressed
Figure 3. Overview of the cell-based genetic selection assays performed using the random small RNA expression library. (A) Plasmid
DNA from the random siRNA library was transfected into a mixture of Amphopack HEK293 and PG13 packaging cells. The viral containing medium
was used to infect 62% of HCT116 cells. Following selection in G418, stably trasnduced cells were subjected to two independent genetic selections
involving treatment with 5FU or TNF-a plus cycloheximide (chx). At 14 days after removal of the selective agent, independent surviving colonies were
isolated and subjected to PCR to recover resident library vector inserts. These sequences were used for target identification and insert 5FU55 was re-
cloned into pHybrid for re-delivery and validation. (B) Percentage and number of clones recovered from the two genetic selections. The filled portion
of the histograms represents the numbers associated with the library-containing population (positive) and the open portion indicates the vector
alone (vector).
doi:10.1371/journal.pone.0004758.g003
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capable of producing the same modified protein expression profile
and altered complex cellular phenotype.
Most of the gene-expressed RNAi libraries used for target
identification and validation have been produced using computer
algorithms and previously known genes or gene families. These
designs have incorporated single promoters controlling shRNAs
[16,17] or dual opposing promoters driving expression of
complementary sense and antisense RNAs [22], and required
computational prediction of accessible target sites. One alternative
that complements these targeted libraries, and eliminates the need
for computational prediction and experimental confirmation of
effective RNAi effectors, is the use of RNAi expression libraries
containing randomised inserts. In this study we report on the
construction, characterisation and application of a random RNAi
library using convergent RNA polymerase III promoters based in
a retroviral vector. There are several advantages associated with
this form of RNAi expression library. Firstly, the opposing
promoter arrangement leads to the production of two comple-
mentary RNAs that have the potential to form not only dsRNA
and mediate RNAi-directed gene silencing, but also small RNA
effectors that can operate through other pathways. These include
single stranded antisense RNA, sense RNA, or miRNAs [32]. This
expands the kind of RNA effectors and therefore the intracellular
pathways that can be used for silencing gene expression. Secondly,
the library reported in this study is replete of repeat sequences thus
eliminating instability. Thirdly, the RNA polymerase III promot-
ers can be used in different cellular systems, thus expanding the
applicability of the library. Fourthly, a random library is not
restricted to known genes or protein coding genes as targets. It can
encode small RNA effectors capable of targeting ncRNAs, the
latter of which have been shown to contribute to complex disease-
associated phenotypes [33]. Finally, this form of RNAi library is
cost-effective and amenable to use in both small and large
laboratories for gene discovery and identification of small RNA
effectors, especially when used in combination with functional
genetic screens or selections.
One of the criticisms associated with the use of randomized
RNAi expression libraries is the limited number of representative
inserts that can be incorporated into an expression vector. For
example, it is not possible to construct and screen all insert
sequences of 19 bases as this would require a library of 2.7610
11
different constructs. However, it has been well reported that small
RNAs can be effective against single and multiple target mRNAs
with incomplete complementarity [34,35]. Studies with synthetic
siRNAs have identified the limited requirements for an effective
guide strand [36–38]. Mutations within termini of siRNA do not
significantly impact silencing [39]. Moreover, mRNAs with as few
as 11 nucleotides of homology can be regulated by a siRNA [34].
Even if mismatches within the body of a siRNA reduce or
eliminate its ability to mediate target mRNA cleavage, it is possible
that this duplex RNA could still operate as a miRNA-like
translational inhibitor [36]. Furthermore, naturally occurring
miRNAs only require matches within an eight base seed region
to mediate control of up to 200 different protein coding targets
[40]. The above indicates that convergent small RNA libraries
have the potential to encode multiple effectors without the need
for precise sequence complementarity.
By combining the random RNAi library with cell-based genetic
selections, it is possible to identify RNA modulators of complex
phenotypes both for use as biological tools and potential
therapeutics. In this study we used the library in two functional
genetic selection assays to identify small RNA effectors capable of
overcoming cell death induced by a chemotherapeutic agent (5FU)
or a cytokine (TNF-a). Unique insert sequences were identified
within each genetic selection with few clones containing the same
insert sequence. This is not surprising considering that most
genetic selections require multiple rounds of re-selection to enrich
for specific inserts [12]. There were no shared sequences between
the two different genetic selections. This may reflect the different
biological pathways used by 5-FU and TNF-a for mediating cell
death. Furthermore, the sequences identified following genetic
selection in mammalian cells were not present among the bacterial
plasmids sequenced in the pre-selected library. Interestingly, even
with a single round of genetic selection, we were able to identify a
single insert enriched in a third of all 5FU resistant clones. More
recently, we have expanded the utility of this expression library
and identified ten small RNA effectors conferring resistance to
cellular infection by the respiratory syncytial virus (Fred
Delvecchio, unpublished results). Further analysis of the insert
sequences identified through the different genetic selections did
not reveal the presence of common ‘‘seed’’ regions or extended
sequence similarity or complementarity with previously reported
human miRNAs. The power of this approach is its unbiased
nature that permits the cell itself to identify effective RNA agents
that alter specific cellular phenotypes without directing cell
toxicity. These RNA modulators have the potential to be used
as gene-expressed or synthetic RNA leads for therapeutic
development [28].
One common theme observed in using random RNAi
expression libraries in unbiased genetic screens is the difficulty in
translating the identified small RNA effector sequence into
identification of the direct targets, the latter of which provide a
better understanding of the underlying mechanism associated with
modifying a complex disease-associated phenotype and specific
candidates for conventional drug development [28]. In this study a
simple sequence homology search indicated that the inserts
identified through the two different selection assays did not
recognise any sequences within the human transcriptome with
complete complementarity and instead recognised between 7 and
20 different targets, using the criteria of 14 bases of contiguous
homology. This suggested that all the effectors identified operate
through control of multiple target genes to alter the phenotype
under study, most probably through the promiscuous nature of the
RNAi/miRNA machinery in mammalian cells [41,42]. Given the
random nature of the convergent RNAi expression library it was
not surprising that it was difficult to identify precise targets of the
effector RNAs. It is likely that these sequences do not exist in
nature, may act through novel mechanisms and have both direct
and indirect targets. Work with random shRNA libraries identified
Figure 4. Resistance to 5FU conferred by 5FU55. (A) Re-delivery and validation of pHybrid-5FU55 as conferring resistance to 5FU. The original
5FU55 insert was subcloned into pHybrid and re-delivered to HCT116 cells via retroviral transduction. Independent clones were isolated, exposed to
5FU for 48 h and then assessed for colony numbers at 14 days. Panel 1: pHybrid vector alone treated with 5FU. Panel 2: clone 6 containing the
pHybrid-5FU55 vector and treated with 5FU. Panel 3: clone 8 containing the pHybrid-5FU55 vector and treated with 5FU. Panel 4: clone 8 containing
the pHybrid-5FU55 vector without prior exposure to 5FU. (B) Transient transfection with 5FU55 siRNA produces increased resistance to 5FU. HCT116
cells were transfected with two different concentrations (open histograms=30 nM; filled histograms=60 nM) of either negative control siRNA or
5FU55 siRNA. After 48 h, cells were exposed to 5FU for 18 h and then re-seeded. At 14 days, colonies were stained with crystal violet and counted.
doi:10.1371/journal.pone.0004758.g004
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however these authors could not identify specific targets using
simple homology searches or miRNA target prediction algorithms
[28]. Further experimentation will be required in order to expand
the random small RNA library approach to gene identification.
Toward this end, the ‘‘rules’’ being identified for naturally-
occurring miRNAs may provide an inroad to deciphering the
molecular targets of the identified functional small RNAs.
In the case of the 5FU55 effector, we identified homeodomain-
interacting protein kinase-2 (HIPK2) as one potential target. The
development of resistance to 5FU is multifactorial and several
different mechanisms have been reported [43–45]. These include
loss of sensitivity to apoptosis, increased expression of DNA repair
genes, changes in fluoropyrimidine metabolism, and altered drug
transport. Our observation that HIPK2 is a potential target for the
5FU55 siRNA implicates one alternative pathway for invoking
cellular resistance to 5FU. HIPK2 is a transcriptional co-repressor,
and its suppression has been shown to inhibit chemotherapeutic
drug-induced apoptosis [46]. For example, DNA damage induced
by cisplatin or adriamycin activates HIPK2, leading to phosphor-
ylation of p53 on serine 46 and activation of p53-mediated
apoptosis [46–48]. A block in this cellular response pathway can
lead to chemotherapeutic resistance. In the present study,
inhibition of HIPK2 by the 5FU55 siRNA may have prevented
transcriptional repression of the HIF-1 transcriptional activator.
One result would be the induction of HIF-1 targets genes
including the multidrug resistance gene MDR1 and the anti-
apoptotic protein Bcl2 [49]. In addition, a reduced level of HIPK2
would impair activation of p53-directed apoptosis via DNA
damage resulting from FdUTP misincorporation into DNA. The
end result would be a multifactorial response leading to 5FU
resistance. Interestingly, a subunit of HIF-1, HIF-1a, has been
reported as being overexpressed in colorectal tumors and
contributing to chemotherapeutic resistance [50]. The validity of
these proposed mechanisms will require further experimentation.
The integrative approach using random small RNA libraries
and cell-based genetic selection provides a novel technology
platform for identifying RNA effectors capable of modifying
complex cellular phenotypes through control of the expression
level of multiple targets. These RNA effectors have the potential to
be used as novel therapeutic candidates and tools for deciphering




HCT116 colorectal cancer cells were cultured in McCoy’s
medium (Invitrogen) containing 10% FBS, penicillin, streptomy-
cin, and glutamine. Amphopack HEK293 (Invitrogen) and PG13
packaging cell lines were maintained in Dulbecco’s modified
Eagle’s medium (Invitrogen) containing 10% FBS, penicillin,
streptomycin, glutamine and sodium pyruvate.
Plasmid construction
To establish a vector system in which convergent promoters drive
the expression of short complementary RNAs, we modified the
pLXSNretroviralvector(Clontech)toincludeconvergenthumanU6
and H1 RNA polymerase III promoters. The U6+1 promoter
contained in pTZ(U6+1) (gift from David Engelke) was PCR-
amplified using the following forward and reverse primers: 59-
GCGCCTCGAGATAGGGAATTCGAGCTCGGTA-39 and 59-
GCGCGGATCCTTGTAAACGACGGCCAGTGC-39. Following
digestion with XhoI and BamHI, this DNA fragment was ligated into
the multiple cloning site of the retroviral vector pLXSN to produce
pLXSN(U6+1). The H1 promoter region was PCR-amplified from
pSilencer 3.0 (Ambion) using the primers 59-GCCTGCAGGA-
TATTTGCATGTCGCTATGTTCTGG-39 and 59-GCTCTA-
GAGAGTGGTCTCATACAGAACTTATAAG-39,d i g e s t e dw i t h
XbaI and SbfI, and inserted into the pLXSN(U6+1) vector to
produce pHybrid.
To test the effectiveness of pHybrid for regulating the expression
of an endogenous gene, we constructed a derivative encoding
complementary p53-specific sense and antisense RNAs [6]. To this
end, the following oligonucleotide was synthesised: 59-
CGGTGATTCCCTCGAGCAAAAAGACTCCAGTGGTAAT-
CTACTTTTTCTAGAGGTAACAGGCGC-39. Following enzy-
matic generation of the second strand (as described below), the
DNA insert was digested with XhoI and XbaI and ligated between
the U6 and H1 convergent promoters in pHybrid to produce
pHybrid-p53.
Enzymatic synthesis of random siRNA insert
A 63 base oligonucleotide template (59-CGGTGATTCCCTC-
GAGCAAAAAN19TTTTTCTAGAGGTAACAGGCGC-39)c o n -
taining 19 random nucleotides (bold) flanked by five adenosines and
five thymidines, XhoI and XbaI restriction sites (underlined) and
primer binding sites was synthesised and PAGE-purified (Interna-
tional DNA Technologies). A DNA primer (59-
GCGCCTGTTACCTGTAG-39) was annealed to this template
and the complementary strand was synthesised by primer extension
using Klenow DNA polymerase. This double-stranded DNA was
amplified with PCR primers, 59-CGGTGATTCCCTCGAGC-39
and 59-GCGCCTGTTACCTGTAG-39. The PCR conditions
c o n s i s t e do f2 5c y c l e so f9 4 uC for 30 sec, 60uCf o r3 0s e c ,a n d
72uC for 45 sec. Purified PCR amplicons were digested with XhoI
and ligated to SalI-digested and dephosphorylated pHybrid, with a
picomole end ratio of 1:250 for vector to insert. The ligation products
were separated on a 5% Nusieve agarose gel (Cambrex) and the
fragment representing the ligation product excised, extracted and
purified using a Qiagen gel extraction kit. These ligation products
were subsequently digested with XbaI, purified by phenol/chloro-
form extraction and ethanol precipitation, and subjected to
intramolecular ligation to re-circularise all plasmids.
Library construction
The ligation mixture described above was electroporated into
ElectroMAX DH5a-E competent cells (Invitrogen) and the
transformed cells plated on 10 cm LB agar plates containing
50 ug/ml carbenicillin. With 2.5 ug ligation mixture, a total of
4.5610
5 clones were obtained with 95% of these plasmids
containing inserts. DNA sequence analysis of 384 clones indicated
the presence of unique inserts and a random distribution of
sequences when aligned to the human genome sequence. The
library clones were amplified for 48 h at 30uCi n2 6LB semi-solid
agar containing 50 ug/ml carbenicillin according to the manu-
facturer’s protocol (Invitrogen). Plasmid library stocks were
obtained and plasmid DNA prepared using the Qiagen plasmid
purification kit.
Retroviral delivery of pHybrid-p53 or random library and
stable cell line production
A total of 4.5610
6 Amphopack HEK293 and 6610
5 PG13
packaging cells were transfected with 30 ug retroviral-based small
RNA library plasmid DNA using Lipofectamine 2000 (Invitrogen)
according to the manufacturer’s instructions. Medium containing
recombinant virus was recovered two days after transfection and
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HCT116 cells for 24 h. Infected cells were selected by adding
McCoy’s medium, containing 500 ug/ml G418, at 48 h post-
transduction. A stable pooled population was obtained eight days
post-selection. For pHybrid and pHybrid-p53, the stable pooled
populations were serially diluted to isolate single clones. For the
random small RNA library, the stable pooled population was
subjected to treatment with either 5-FU or a combination of TNF-
a and cycloheximide (see below).
Synthetic siRNA transfection
RNA oligonucleotides composing the siRNAs were annealed
according to the manufacturer’s specifications (Proligo). The
sequences were as follows: Dicer (sense: 59-UGCUUGAAGCAG-
CUCUGGA dT dT-39;a n t i s e n s e :5 9-UCCAGAGCUGCUU-
CAAGCA dT dT-39); 5FU55 (sense: 59-AGCUAAGGAUGC-
CAGGGAAUU-39;a n t i s e n s e :5 9-UUCCCUGGCAUCCUU-
AGCUUU-39). A non-specific siRNA (sense: 59- ACUCUAUCUG-
CACGCUGACUU-39; antisense: 59-GUCAGCGAGCAGAUA-
GAGUUU-39) was used as a negative control (Dharmacon). Various
concentrations of siRNA oligonucleotide duplexes were transfected
into 2610
5 HCT116 cells alone or HCT116 cells stably transfected
withpHybrid or pHybrid-p53 using Lipofectamine2000 (Invitrogen).
At 4 h post-transfection, the transfection mixture was replaced with
medium containing 10% FBS, glutamine, penicillin and streptamy-
cin. Cells were harvested 24 and 48 h post-transfection for Western
blot analysis.
Western blot analysis
Pooled populations and stable clones of HCT116 cells,
containing pHybrid-p53, were collected at 80% confluency. Cells
transfected with synthetic siRNA oligonucleotides were harvested
48 h post-transfection. All collected cell pellets were solubilised
and 20 ug of cell lysate separated using 5–12% SDS-PAGE
(Novex). Proteins transferred to PVDF membranes (Invitrogen)
were probed for the p53 (Oncogene Research) or b-actin (Sigma)
proteins, followed by goat HRP-conjugated antibody to mouse
IgG (Santa Cruz) or HRP-conjugated antibody to rabbit IgG
(Santa Cruz) and detected by chemiluminescence. Immunoblot
signal intensity was quantified using ImageQuant software
(Molecular Dynamics).
Genetic selections
A total of 4610
6 HCT116 cells containing the random
expression library were treated with either 400 uM 5-FU for
18 h or 25 ng/ml TNF-a and 50 ug/ml cycloheximide for 72 h.
Cells treated with either 5-FU or TNF-a plus cycloheximide were
reseeded at 2610
5 cells in T150 cm
2 flasks and allowed to form
colonies for 10–14 days in the absence of 5-FU. Single colonies
were isolated and genomic DNA was purified using Qiagen
genomic DNeasy tissue kit. Recovery of siRNA expression
constructs from genomic DNA was accomplished by PCR with
primers 59- GAACCTCCTCGTTCGACCCCGCCTCGATCC-
39 and 59-GAGCCTGGGGGACTTTCCACACCCTAACT-
GAC-39. The PCR conditions consisted of 40 cycles of 94uC for
1 min, 60uC for 1 min, and 72uC for 1 min. The PCR products
were subjected to DNA sequence analysis. To validate inserts from
the initial genetic selections, the recovered PCR products were
digested with XhoI and XbaI and re-ligated to pHybrid. The
recombinant plasmids were purified and re-delivered to HCT116
cells using retroviral transduction. Stable clones were isolated and
re-analysed for clonogenic growth over 10–14 days, following pre-
treatment with or without 5-FU, as indicated above.
Assessing 5FU55 siRNA in clonogenic assay
HCT116 cells were seeded at 7610
4 cells per well in a 6-well
plate. At 24 h after seeding, cells were transfected with 5FU55
siRNA or the non-specific control siRNA (Dharmacon) using two
different concentrations and Lipofectamine 2000 according to the
manufacturer’s instructions. Transfection efficiency was monitored
using the siGLO RISC-free siRNA (Dharmacon). At 48 h post-
transfection, cells were treated with or without 400 uM 5-FU for
18 h and then reseeded at 2.5610
4 cells and allowed to form
colonies for 10–14 days. Colonies were visualised and quantified
following staining with crystal violet.
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